ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

ASBMT Installs New Officers

March 14, 2003

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

FDA Approves Medication For Smoking Cessation

May 26, 2006

Stronger Federal Role Needed To Improve Palliative Care.

June 22, 2001